Key insights
- Aptiv completed a $1.37 billion debt tender offer, restructuring its senior notes. This move reduces future interest expenses and potentially improves the company's financial flexibility. While positive for Aptiv, the impact on the broader US equity market is minimal, reflecting company-specific financial management rather than a macro trend.
SCHAFFHAUSEN, Switzerland - Aptiv PLC (NYSE:APTV) completed its cash tender offer to purchase up to $1.37 billion of outstanding senior notes through its subsidiary Aptiv Swiss Holdings Limited, according to a press release statement. The debt restructuring comes as the $12.98 billion market cap company trades below its InvestingPro Fair Value, suggesting potential upside for investors.
The tender offer expired at 5:00 p.m. New York time on Thursday. The company accepted $1.37 billion in aggregate principal amount across six series of notes, with payment scheduled for Monday.
The accepted notes include $456.5 million of 3.250% senior notes due 2032, $370.5 million of 5.150% senior notes due 2034, $303.8 million of 5.750% senior notes due 2054, $123.5 million of 5.400% senior notes due 2049, $111.7 million of 4.400% senior notes due 2046, and $79.6 million of 4.150% senior notes due 2052. The company maintains a current ratio of 1.74 with total debt of $8.09 billion as of the last twelve months.
The 4.150% senior notes due 2052 were subject to a series cap of $100 million and accepted at a proration factor of 19.2%. The company did not accept any of the 3.100% senior notes due 2051 for purchase.
Notes were accepted based on a priority system, with the 2032 notes receiving highest priority and the 2051 notes receiving lowest priority. The majority of notes were tendered by the early tender deadline, with minimal additional tenders submitted between the early deadline and final expiration.
Citigroup Global Markets Inc., Goldman Sachs & Co. LLC, and J.P. Morgan Securities LLC served as dealer managers for the tender offer. Global Bondholder Services Corporation acted as tender and information agent.
Aptiv is a global technology company focused on automated, electrified, and digitalized solutions across multiple end-markets. For deeper insights into Aptiv’s financial health and access to exclusive Pro Research Reports covering this and 1,400+ other US equities, visit InvestingPro.
In other recent news, Aptiv PLC has completed the spin-off of Versigent Limited, with shares of the new entity beginning to trade independently on the New York Stock Exchange. The separation process was finalized, and Aptiv distributed all outstanding ordinary shares of Versigent to its shareholders on a pro rata basis. As part of this strategic move, several financial firms have adjusted their price targets for Aptiv. UBS has lowered its price target to $80, while maintaining a Buy rating, reflecting the firm’s 2027 earnings per share estimate for the stand-alone Aptiv, excluding Versigent. Similarly, TD Cowen reduced its price target to $93, also maintaining a Buy rating, after updating its estimates to incorporate the spin-off and recent industry data. Additionally, RBC Capital has adjusted its price target to $81, maintaining an Outperform rating, citing the valuation of Aptiv without its VGNT business. Meanwhile, Versigent has expanded its board by appointing Paul Meister as a director, who will serve on multiple committees, ensuring compliance with financial and governance standards. These developments mark significant changes for both Aptiv and Versigent in their respective business trajectories.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.